RNA Clinical Trials Videos
-
Precision ADVANCE: Unravelling The Complexity Of CGTx Development
10/12/2021
Need help unravelling the complexity of CGTx development? Four experts explain Precision ADVANCE’s unique approach. Spend 50 seconds with Anshul Mangal, Deb Phippard, Megan Liles, and Philip Cyr.
-
The Scientific Underpinnings Of mRNA/LNPs
11/28/2022
In this video, Russell Johnson, VP Formulation Research for RVAC Medicines, and Aalok Shah, Director of Formulation & Drug Delivery, Strand Therapeutics, share their thoughts on the scientific-research and CMC-related reasons that have made the lipid nanoparticle the “darling” of the delivery world for mRNA/RNA products today.
-
Goldilocks & The 3…CQAs? Finding "Just Right" With LNP Optimization
12/4/2024
Three LNP experts from Sanofi, Hopewell Therapeutics, and BioNTech collectively discuss how far we’ve come in understanding the structure of our LNPs while also shedding light on the variables that have the greatest potential of causing shifts in our products’ structure/function.
-
Obesity, From The Bench To The Bedside
12/2/2025
Watch as experts in a multidisciplinary panel discuss the biological and clinical burden of obesity, emerging innovations in biotech and clinical practice, and patient experiences and societal factors.
-
What Have We Learned About Our LNP's Function In Vitro In 2024?
12/4/2024
BioNTech’s Ben Muir shares a high-level overview of the LNP preclinical research advances that are the most exciting/promising today — while also reminding us of a few important caveats that accompany early-stage research.
-
Early Phase Excellence: Navigating B Cell Therapies In Autoimmune Conditions
12/2/2025
Follow along as expert panelists share insights into the most critical considerations for navigating early-phase clinical development and designing studies that reliably translate mechanisms into meaningful patient outcomes.
-
Shaping Therapeutic Development With Cutting-Edge CRISPR Nucleases
6/4/2025
Gain an understanding of how an advanced nuclease portfolio is designed to support CRISPR-based cell and gene therapy development, providing scientists with the best solutions for therapeutic success.
-
Navigating The Early Oncology Landscape: Market Trends And Insights
5/14/2025
Explore the evolving landscape of early-phase oncology clinical trials, including strategic insights to empower operations teams in optimizing study design, site selection, and recruitment.
-
Approving The World's First saRNA Vaccine: Arcturus' Regulatory Experience
5/10/2024
Explore the behind-the-scenes best practices of the company implemented that led to the approval of the world’s first saRNA vaccine in Japan.
-
Accelerating Development In Novel & Advanced Oncology Therapies
6/15/2023
Hear from a panel of industry experts on dissecting the shift in early-phase oncology design, focusing on Bayesian Data.